What is Automated Insulin Delivery?
AID systems increase and decrease insulin delivery based on sensor-derived glucose levels to mimic physiologic insulin delivery1. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
Dexcom G6 and G7 are sold separately, require a separate prescription and must be used with the Dexcom mobile app to use automated mode. The Dexcom receiver is not compatible.
A hybrid closed loop of control
AID systems create a circle of constant communication between your diabetes devices.
Generally, every 5 minutes:
- The CGM reports your glucose levels to the insulin pump or Pod
- The pump or Pod then adjusts its insulin delivery using an insulin control algorithm
- The CGM picks up on any changes to your glucose level, reports that to the insulin pump or Pod, and so on
With AID systems, users still need to bolus for meals. With Omnipod 5, this is done with the Omnipod 5 App or Omnipod 5 Controller that is provided with your first prescription.
New to CGM sensors?
These wearable glucose monitors are an essential piece of AID systems. They can also tell you a lot about your personal glucose trends. Get all the facts.
The real sciencey side
AID systems contain algorithm software, the “brains” of the system, that crunch the numbers to predict where glucose levels are headed and tell the pump what to do.
- An eye to the future: The Omnipod 5 SmartAdjust™ technology predicts trends 60 minutes out and automatically adjusts insulin delivery using the users set glucose target, helping to protect against highs and lows during the day and while you’re sleeping.2
The real-life side
AID systems may lessen the burden of managing your diabetes, helping you feel free from having to think about manually controlling it around the clock, especially during times of increased hypoglycemia risk.
- Activity with a few taps: For times when your blood glucose typically goes low, like during exercise, enabling the Omnipod 5 Activity feature will automatically reduce insulin delivery.
Pump to Pod: Equals no more tubes
AID has already been available with traditional insulin pumps, but the release of Omnipod 5 marks the first and only tubeless AID system in the US. Rather than controlling everything through a pump with tubes, the Omnipod 5 App gives full control of the Pod, right from a compatible smartphone. You know you’re looking at it all day, anyway.
See our full list of compatible smartphones.
Curious about Omnipod 5?
Learn all about the only tubeless AID system available.
2. Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average overnight time (12AM-6AM) with high blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 32.1% vs. 20.7%; 42.2% vs. 20.7%. Average day time (6AM-12AM) with high blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 32.6% vs. 26.1%; 46.4% vs. 33.4%. Median overnight time (12AM-6AM) with low blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 2.07% vs. 0.82%; 0.78% vs. 0.78%. Median day time (6AM-12AM) with low blood glucose in adults/adolescents and children for standard therapy vs. Omnipod 5 = 1.91% vs. 1.08%; 1.17% vs. 1.62%. Brown et al. Diabetes Care (2021).
Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose overnight from CGM in standard therapy vs. Omnipod 5 = 38.4% vs. 16.9%. Average time with high blood during daytime from CGM in standard therapy vs. Omnipod 5 = 39.7% vs. 33.7%. Average time with low blood glucose overnight from CGM in standard therapy vs. Omnipod 5 = 3.41% vs. 2.13%. Average time with low blood glucose during daytime from CGM in standard therapy vs. Omnipod 5 = 3.44% vs. 2.57%. Sherr JL, et al. Diabetes Care (2022).